Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


McKesson Corporation (MCK), a health care and pharmaceutical products distributor, said on Wednesday that it has raised earnings guidance for the next fiscal.


RTTNews | Dec 8, 2021 08:57AM EST

08:56 Wednesday, December 8, 2021 (RTTNews.com) - McKesson Corporation (MCK), a health care and pharmaceutical products distributor, said on Wednesday that it has raised earnings guidance for the next fiscal.

For the fiscal 2022, the Texas-based company now expects its adjusted earnings per share to be in the range of $22.35 - $22.95, against its previous projection range of $21.95 - $22.55. The revised guidance aims to reflect an additional $0.40 related to the federal government's Covid-19 vaccine distribution program.

In addition, McKesson has also announced new $4 billion increase to its share repurchase program authorized by the Board.

Commenting on its future growth strategies, the company said, it will leverage the breadth and depth of its core growth to further develop and build differentiated oncology and biopharma services ecosystems.

Read the original article on RTTNews ( https://www.rttnews.com/3247805/mckesson-raises-fy22-earnings-guidance-announces-4bln-rise-in-share-buyback-drive.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC